(Q48378465)

English

Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.

scientific article published in August 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

0 references

ventricular dysfunction

1 reference

based on heuristic

inferred from title

left ventricular dysfunction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Selvais PL

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Donckier JE

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Robert A

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Laloux O

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

van Linden F

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Ahn S

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Ketelslegers JM

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Rousseau MF

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

publication date

1 August 1998

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

European Journal of Clinical Investigation

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

28

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

636-642

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

The plasma release of atrial natriuretic peptide in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Plasma atrial natriuretic peptide is unstable under most storage conditions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Effect of exercise on plasma atrial natriuretic factor and cardiac function in men and women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2362.1998.00338.X

21 January 2018

Identifiers

10.1046/J.1365-2362.1998.00338.X

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/9767358

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48378465&oldid=1528531434"